Nitroglycerin shortage has medical community worried

March 27, 2014
Nitroglycerin shortage has medical community worried

(HealthDay)—An ongoing shortage of the drug nitroglycerin is causing problems and concerns for doctors and hospitals in the United States. The drug is often the first therapy used by emergency room doctors when treating a heart attack patient.

"It's one of those drugs that in certain circumstances, there really is no substitute for," Frederick Blum, M.D., an emergency doctor who treats patients at Ruby Memorial Hospital in West Virginia, told The New York Times. He added that nitroglycerin supplies are so low that "if we had one or two patients that were really sick that needed extended drips, it could exhaust our supply pretty quickly."

Hospitals and doctors became concerned they might run out of the drug when Baxter International, the only U.S. manufacturer of injectable nitroglycerin, recently said it was slashing shipments of the drug, The Times reported.

This week, Baxter and the U.S. Food and Drug Administration said they were taking action to ease the shortage of nitroglycerin.

Explore further: FDA takes action to ease neonatal drug shortage

More information: Health Highlights: March 26, 2014

Related Stories

FDA takes action to ease neonatal drug shortage

May 29, 2013

(AP)—Federal health regulators will allow overseas imports of a critical intravenous drug formula used to nourish premature infants, amid a shortage that has impacted hospitals nationwide.

ERs dispensing more narcotic painkillers, study finds

March 21, 2014

(HealthDay)—More and more Americans are being prescribed powerful narcotic drugs when they visit the emergency department for problems such as low back pain or a pounding headache, a new study finds.

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.